SUBMIT YOUR PITCH
PORTFOLIO NEWS

Nolqa Invests in Eterna Regeneratives

Building new approaches to regenerative medicine

Biotechnology & Regenerative Medicine London, UK

Today we are pleased to welcome Eterna Regeneratives to the Nolqa portfolio. We invested $660K to support the company as it builds its next stage of growth.

What Eterna Regeneratives does

Eterna Regeneratives is a biotechnology company focused on regenerative medicine. Its work is aimed at developing new biological approaches that can support tissue repair and address areas of unmet medical need.

Why we invested

We invested because regenerative medicine offers the potential to change treatment paradigms in areas where conventional approaches have limitations. Eterna is working in a scientifically ambitious category with a clear long-term opportunity.

What comes next

We will support Eterna as it advances its research, develops its pipeline and works toward translating regenerative science into future therapies.

Nolqa investment$660K
CategoryBiotechnology & Regenerative Medicine
LocationLondon, UK

We are looking forward to working closely with the team and helping Eterna Regeneratives build the next chapter of the business.

Explore more of the companies we back.

VIEW PORTFOLIO
Home About Approach Portfolio Team Contact SUBMIT YOUR PITCH